Ophthalmology Times Staff Reports

1245 S UTICA AVE

Articles

FDA approves topical corticosteroid for treatment of dry eye disease

The FDA has approved loteprednol etabonate ophthalmic suspension 0.25% for short-term treatment of the signs and symptoms of dry eye disease.

Bausch Health: Spin-off of eye health business

This action will result in 2 separate companies,

Ophthalmologist-Mayor Deirdre Waterman on healing a community amid pandemic, protests